Fabtech Technologies, a turnkey engineering solutions provider for pharmaceuticals, biotech and healthcare industry, on September 24 fixed a price band of Rs 181-191 per share for its upcoming over Rs 230-crore initial public offering (IPO).
In its statement, the Mumbai-based company said its initial share-sale will open for public subscription on September 29 and conclude on October 1.
The company's IPO is entirely a fresh issue of up to 1.2 crore equity shares worth Rs 230 crore at the upper end of the price band.
Proceeds from the IPO will be used for funding the working capital requirements of the company, pursuing inorganic growth initiatives through acquisitions, and general corporate purposes.
Fabtech Technologies offers comprehensive start-to-finish solutions encompassing designing, engineering, procurement, installation and testing of select pharmaceutical equipment for a wide range of customers.
Click Here To Read All IPO News
Till June 2024, the company had completed 35 projects across countries, including Saudi Arabia, Egypt, Algeria, Bangladesh, Ethiopia, Sri Lanka, and the UAE.
Unistone Capital is the sole book-running lead manager to the issue.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
